Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China

NCT02898922 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B Vaccines

Interventions

BIOLOGICAL: hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae

Sponsor

Shandong Province Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]